Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program Cancer Treatment Support in Partnership With the Cancer Support Community
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 18
- 试验地点
- 2
- 主要终点
- Feasibility of Integrating Chatbot in Clinic
研究概览
简要总结
This study is designed to study the feasibility and acceptability of the Open to Options (O2O) Chatbot prototype. The O2O program is an existing patient support program with content currently delivered via in-person counseling with a trained mental health professional or via an existing web-based program (Let's Talk Treatment Options).The Chatbot is an automated, menu-based agent being developed in this study to extend the reach and accessibility of the O2O program via the Chatbot's "virtual coaching".
详细描述
This is a pilot study to assess feasibility and acceptability, and to gather preliminary data on how patients with a diagnosis of cancer appraise being prepared for their upcoming visit with a cancer specialist. Participants will be randomized to take a survey either before or after their Chatbot interaction. The surveys collect participants' self-appraisal regarding preparedness for their upcoming appointment with a cancer physician, cancer distress and cancer anxiety. The study will examine whether patients who take the survey after viewing the Chatbot feel more prepared for their upcoming appointment than those who take the survey before the Chatbot interaction.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with a cancer diagnosis
- •Able to speak and read English, and willing to electronically consent
- •Appointment with a Rogel Cancer Center cancer clinician within the next 3 weeks
- •Patient must have a way to access the internet (includes mobile phone)
排除标准
- •Age <18 years
- •Inability to speak or read English
- •Inability to give informed consent
结局指标
主要结局
Feasibility of Integrating Chatbot in Clinic
时间窗: At the time of scheduling an appointment with cancer physician; one day
The feasibility of integrating an Open to Options (O2O) Chatbot into the clinical workflow, assessed by the number of patients who accept the invitation to receive more information about the study, among all those invited.
Acceptability - Reach
时间窗: Baseline (Before appointment with cancer physician); up to approximately 3 weeks after scheduling appointment
Assessed by the number of patients who log-in to the O2O Chatbot program and create an account, among all those who accepted the invitation to receive information.
Acceptability - Uptake
时间窗: Baseline (Before appointment with cancer physician); up to approximately 3 weeks after scheduling appointment
Assessed by the number of patients who proceed to view the full Chatbot prototype and generate a summary, among all those who created an account.
Acceptability - Mean Satisfaction Scores
时间窗: Baseline (Before appointment with cancer physician); up to approximately 3 weeks after scheduling appointment
Post-Intervention Survey Group only: In addition to the survey given to all participants, the post-intervention survey group will answer 6 questions about their perception of the Chatbot prototype. Each of the 6 questions will be scored on a scale from 1 (strongly disagree) to 5 (strongly agree). Investigators will calculate the mean value (and Standard Deviation) on a 1-5 scale for each question.
Acceptability - Percent of Participants with High Satisfaction Scores
时间窗: Baseline (Before appointment with cancer physician); up to approximately 3 weeks after scheduling appointment
Post-Intervention Survey Group only: In addition to the survey given to all participants, the post-intervention survey group will answer 6 questions about their perception of the Chatbot prototype. Each of the 6 questions will be scored on a scale from 1 (strongly disagree) to 5 (strongly agree). For each of the six questions, investigators will calculate the percentage of participants who strongly agree.
次要结局
未报告次要终点